Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 21, 2019Bioscience ReportsOpen Access

BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

JYJiawei YinHebei University of EngineeringXXXiaoli XieKunming University of Science and TechnologyYYYufu YeMinistry of Public Health

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yin et al. (2019) studied this question.

synapsesocial.com/papers/69df4d06915fa049536147bdhttps://doi.org/10.1042/bsr20190604
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Global cancer statistics, 20122015 · 27,467 citations
  2. 2Tracking the Evolution of Non–Small-Cell Lung Cancer2017 · 2,504 citations
  3. 3Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major2018 · 118 citations
  4. 4The BCL11A-XL expression predicts relapse in squamous cell carcinoma and large cell carcinoma.2015 · 15 citations
  5. 5BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification2013 · 55 citations